BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 23567118)

  • 1. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins.
    Jian JW; Chiu WC; Chang HT; Hsu PH; Huang CC
    Anal Chim Acta; 2013 Apr; 774():67-72. PubMed ID: 23567118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining fibrinogen-conjugated gold nanoparticles with a cellulose membrane for the mass spectrometry-based detection of fibrinolytic-related proteins.
    Chiu WC; Huang CC
    Anal Chem; 2013 Jul; 85(14):6922-9. PubMed ID: 23822658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold nanoparticle-based colorimetric assays for coagulation-related proteins and their inhibition reactions.
    Chen YY; Tseng CW; Chang HY; Hung YL; Huang CC
    Biosens Bioelectron; 2011 Mar; 26(7):3160-6. PubMed ID: 21215609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turn-on colorimetric sensor for ultrasensitive detection of thrombin using fibrinogen-gold nanoparticle conjugate.
    Niu Y; Wang P; Zhao Y; Fan A
    Analyst; 2013 Mar; 138(5):1475-82. PubMed ID: 23324826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using self-assembled aptamers and fibrinogen-conjugated gold nanoparticles to detect DNA based on controlled thrombin activity.
    Chen CK; Shiang YC; Huang CC; Chang HT
    Biosens Bioelectron; 2011 Apr; 26(8):3464-8. PubMed ID: 21324664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis--a review.
    Kane KK
    Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorimetric detection of platelet-derived growth factors through competitive interactions between proteins and functional gold nanoparticles.
    Lin TE; Chen WH; Shiang YC; Huang CC; Chang HT
    Biosens Bioelectron; 2011 Nov; 29(1):204-9. PubMed ID: 21900002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release).
    Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Label-free colorimetric detection of picomolar thrombin in blood plasma using a gold nanoparticle-based assay.
    Chen CK; Huang CC; Chang HT
    Biosens Bioelectron; 2010 Apr; 25(8):1922-7. PubMed ID: 20129774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
    Aoki N; Moroi M; Matsuda M; Tachiya K
    J Clin Invest; 1977 Aug; 60(2):361-9. PubMed ID: 68962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity.
    Echart CL; Graziadio B; Somaini S; Ferro LI; Richardson PG; Fareed J; Iacobelli M
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):627-34. PubMed ID: 19809307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Index of fibrinolysis with new fibrin plate (author's transl)].
    Hishikawa Y; Sugie I
    Nihon Seirigaku Zasshi; 1977; 39(1):1-11. PubMed ID: 140239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in assays of standard SK and plasmin preparations: evidence for and effect of variability of plasmins, plasminogen, and fibrinogen.
    Johnson AJ; Tse A; Skoza L
    Fed Proc; 1966; 25(1):34-41. PubMed ID: 4283648
    [No Abstract]   [Full Text] [Related]  

  • 17. [Plasminogen activation and regulation of fibrinolysis].
    Madoiwa S
    Nihon Rinsho; 2014 Jul; 72(7):1218-23. PubMed ID: 25163311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system.
    Holvoet P; de Boer A; Verstreken M; Collen D
    Thromb Haemost; 1986 Oct; 56(2):124-7. PubMed ID: 2433784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis.
    Matsumoto T; Nogami K; Shima M
    Thromb Haemost; 2013 Oct; 110(4):761-8. PubMed ID: 24072166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR
    Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.